TEVA logo

TEVA Financing Cash Flow

Latest reported-$401.00M
TEVA TTM Cash from Financing ($266.72M → -$401.00M)
High-resolution chart · PNG

TEVA financing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Teva Pharmaceutical Industries Limited American Depositary Shares Financing Cash Flow — Trailing twelve months (TTM) (USD)
Period endingFinancing Cash Flow (USD)
-401,000,000
-394,000,000
-2,151,000,000
-2,865,000,000
-2,412,000,000
-3,384,000,000
-1,791,000,000
-1,693,000,000
-2,269,000,000
-1,358,000,000
-1,913,000,000
-2,050,000,000
-1,913,000,000
-2,196,000,000
-1,488,000,000
-1,276,000,000
-2,014,000,000
-1,677,000,000
-2,172,000,000
-1,796,000,000
-1,676,000,000
-1,678,000,000
-1,885,000,000
-2,001,000,000
-2,405,000,000
-2,437,000,000
-1,926,000,000
-2,184,000,000
-1,428,000,000
-1,449,000,000
-3,351,000,000
-5,358,000,000
-5,478,000,000
-6,073,000,000
-5,750,000,000
-3,945,000,000
22,252,000,000
23,182,000,000
25,217,000,000
30,633,000,000
4,171,000,000
4,979,000,000
4,805,000,000
-503,000,000
258,000,000
-1,648,000,000
-2,375,000,000
-2,401,000,000
-2,328,000,000
-2,257,000,000
-3,883,000,000
-2,998,000,000
-3,312,000,000
-3,325,000,000
-1,678,000,000
2,148,000,000
3,416,000,000
3,493,000,000
3,336,000,000
-1,329,000,000
-2,231,000,000
-22,000,000
573,000,000
933,000,000
240,000,000
-2,416,000,000
-2,265,000,000
-89,000,000
724,000,000
1,222,000,000
1,358,000,000
-761,000,000
-920,000,000
-286,000,000
-362,000,000
-531,300,000
-541,800,000
-524,700,000
2,024,000,000
2,700,400,000
2,797,200,000
2,581,700,000
-312,700,000
-764,000,000
-714,400,000
-544,400,000
852,400,000
986,600,000
1,080,700,000
1,095,900,000
17,400,000
416,000,000
412,500,000
395,500,000
337,500,000
-108,983,000
345,468,000
339,107,000
266,717,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.